Flexiv
Develops and manufactures adaptive robots for complex tasks
UndisclosedStrategic
Role not disclosedActivity from announced rounds
Invus is the investment-firm name used by Encoded Therapeutics and in LifeMine transaction-counsel coverage.
Encoded develops precision gene therapies for neurological disorders. LifeMine uses fungal genomes for drug discovery, while City develops RNA-interference medicines. The records identify different therapeutic approaches without substituting an unnamed parent or fund.
Develops and manufactures adaptive robots for complex tasks